Study of levodopa response in Parkinson's disease: Observations on rates of motor progression

被引:11
|
作者
Ding, Catherine [1 ]
Ganesvaran, Ganga [1 ]
Alty, Jane E. [1 ]
Clissold, Benjamin G. [1 ]
McColl, Craig D. [1 ]
Reardon, Katrina A. [1 ]
Schiff, Mark [1 ]
Srikanth, Velandai [1 ,3 ,4 ]
Kempster, Peter A. [1 ,2 ]
机构
[1] Monash Med Ctr, Dept Neurosci, 246 Clayton Rd, Clayton, Vic 3168, Australia
[2] Monash Univ, Dept Med, Clayton, Vic, Australia
[3] Monash Univ, Dept Med, Sch Clin Sci, Stroke & Ageing Res Grp,Vasc Brain Aging Div, Melbourne, Vic 3004, Australia
[4] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia
关键词
Parkinson's disease; levodopa; dementia; natural history; SUBSTANTIA-NIGRA; DURATION;
D O I
10.1002/mds.26497
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionIt is important to understand how the rate of motor progression in PD relates to dopaminergic treatment. MethodsThe methods for this study comprised prospective defined off state measurements of the levodopa response at 3-year intervals over a mean 13.3-year period in 34 patients enrolled before treatment initiation. ResultsDespite worsening of on and off scores, the magnitude of the l-dopa short-duration response is maintained as the disease progresses. A linear mixed-effects regression analysis of off phase motor scores showed a yearly deterioration of 2.3% of the maximum disability score. Greater motor disability at the commencement of treatment was an independent predictor of faster progression. Demented patients had worse motor function than those without dementia (P = 0.02), and motor deficit appeared to accelerate toward the end of the disease course in patients who had died. ConclusionsThese observations should inform clinical trial design for drugs with possible neuroprotective properties. (c) 2016 International Parkinson and Movement Disorder Society
引用
收藏
页码:589 / 592
页数:4
相关论文
共 50 条
  • [21] Is Levodopa Response a Valid Indicator of Parkinson's Disease?
    Martin, W. R. Wayne
    Miles, Michael
    Zhong, Qiaonan
    Hartlein, Johanna
    Racette, Brad A.
    Norris, Scott A.
    Ushe, Mwiza
    Maiti, Baijayanta
    Criswell, Susan
    Davis, Albert A.
    Kotzbauer, Paul T.
    Cairns, Nigel J.
    Perrin, Richard J.
    Perlmutter, Joel S.
    MOVEMENT DISORDERS, 2021, 36 (04) : 948 - 954
  • [22] Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment
    Marina Senek
    Sten-Magnus Aquilonius
    Håkan Askmark
    Filip Bergquist
    Radu Constantinescu
    Anders Ericsson
    Sara Lycke
    Alexander Medvedev
    Mevludin Memedi
    Fredrik Ohlsson
    Jack Spira
    Jerker Westin
    Dag Nyholm
    European Journal of Clinical Pharmacology, 2017, 73 : 563 - 571
  • [23] Long-Duration Response to Levodopa, Motor Learning, and Neuroplasticity in Early Parkinson's Disease
    Sciacca, Giorgia
    Mostile, Giovanni
    Disilvestro, Ivano
    Donzuso, Giulia
    Nicoletti, Alessandra
    Zappia, Mario
    MOVEMENT DISORDERS, 2023, 38 (04) : 626 - 635
  • [24] Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment
    Senek, Marina
    Aquilonius, Sten-Magnus
    Askmark, Hakan
    Bergquist, Filip
    Constantinescu, Radu
    Ericsson, Anders
    Lycke, Sara
    Medvedev, Alexander
    Memedi, Mevludin
    Ohlsson, Fredrik
    Spira, Jack
    Westin, Jerker
    Nyholm, Dag
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (05) : 563 - 571
  • [25] Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa
    Cilia, Roberto
    Cereda, Emanuele
    Akpalu, Albert
    Sarfo, Fred Stephen
    Cham, Momodou
    Laryea, Ruth
    Obese, Vida
    Oppon, Kenneth
    Del Sorbo, Francesca
    Bonvegna, Salvatore
    Zecchinelli, Anna Lena
    Pezzoli, Gianni
    BRAIN, 2020, 143 (08) : 2490 - 2501
  • [26] Levodopa in the treatment of Parkinson's disease
    Schapira, A. H. V.
    Emre, M.
    Jenner, P.
    Poewe, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (09) : 982 - 989
  • [27] Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa
    Cilia, Roberto
    Cereda, Emanuele
    Akpalu, Albert
    Sarfo, Fred Stephen
    Cham, Momodou
    Laryea, Ruth
    Obese, Vida
    Oppon, Kenneth
    Del Sorbo, Francesca
    Bonvegna, Salvatore
    Zecchinelli, Anna Lena
    Pezzoli, Gianni
    BRAIN, 2020, 143 : 2490 - 2501
  • [28] Study of Istradefylline in Patients with Parkinson's Disease on Levodopa with Motor Fluctuations
    Hauser, Robert A.
    Shulman, Lisa M.
    Trugman, Joel M.
    Roberts, John W.
    Mori, Akihisa
    Ballerini, Rocco
    Sussman, Neil M.
    MOVEMENT DISORDERS, 2008, 23 (15) : 2177 - 2185
  • [29] Rate of motor progression in Parkinson's disease: a systematic review and meta-analysis
    Pauwels, Ayla
    Phan, Albert L. G.
    Ding, Catherine
    Phan, Thanh G.
    Kempster, Peter A.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [30] Rate of Progression of Parkinson’s Disease in Early and Late Prescription of Levodopa
    Rosinskaya A.V.
    Vasenina E.E.
    Khaybullin T.N.
    Levin O.S.
    Neuroscience and Behavioral Physiology, 2019, 49 (7) : 937 - 941